Comparative study of community-acquired pneumonia between diabetic and nondiabetic patients with hyperglycemia

A. Urrutia, R. Zalacain, A. Gomez, L. Martinez-Indart, C. Jaca, M. Alfonso, R. Diez, M. Inchausti, L.A. Ruiz (Barakaldo, Spain)

Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Session: Anti-infective treatment and resistance in respiratory infections
Session type: Poster Discussion
Number: 4369
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Urrutia, R. Zalacain, A. Gomez, L. Martinez-Indart, C. Jaca, M. Alfonso, R. Diez, M. Inchausti, L.A. Ruiz (Barakaldo, Spain). Comparative study of community-acquired pneumonia between diabetic and nondiabetic patients with hyperglycemia. Eur Respir J 2012; 40: Suppl. 56, 4369

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparative study of community acquired pneumonia in diabetes mellitus patients
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Undiagnosed diabetes mellitus in community-acquired pneumonia - A prospective cohort study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018

Impact of diabetes mellitus on microbiological profiles of patients with community-acquired pneumonia in a central hospital
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Particularities of pneumonia in diabetes patients.
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


The comparative analysis of diabetic and nondiabetic cases with tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004

Prevalence and impact of Diabetes mellitus (DM) among hospitalized community-acquired pneumonia (CAP) patients
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006

Statin therapy and reduced risk of pneumonia in elderly patients with diabetes
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


The presence of diabetes mellitus does not influence clinical outcomes in patient with community-acquired pneumonia: Results from the CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010

The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


A clinical study of diabetic or non-diabetic tuberculosis patients: retrospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 89s
Year: 2007

Impact of obesity on outcomes for patients hospitalised with pneumonia
Source: Eur Respir J 2013; 41: 929-934
Year: 2013



The impact of blood glucose on community-acquired pneumonia: a retrospective cohort study
Source: ERJ Open Res, 3 (2) 00114-2016; 10.1183/23120541.00114-2016
Year: 2017



The role of endothelin-1 in hospitalized patients with community-acquired pneumonia.
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019


Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006

The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011

Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002